A 77-Year-Old Woman With Multiple Myeloma

Rafael Fonseca, MD, discusses the case of a 77-year-old woman with multiple myeloma, treatment approach for patients with newly diagnosed multiple myeloma, and the trials providing insight into the treatment of this disease.

EP. 1: Case Overview: Multiple Myeloma

April 20th 2021

Rafael Fonseca, MD, reviews the case overview of a 77-year-old woman with multiple myeloma.

EP. 2: Initial Impressions: Goals and Challenges

April 20th 2021

Rafael Fonseca, MD, discusses the challenges of treating patients with newly diagnosed multiple myeloma.

EP. 3: Considerations for Selecting First-Line Therapy in Newly Diagnosed Multiple Myeloma

April 20th 2021

Rafael Fonseca, MD, reviews first-line therapy options and considerations for treatment selection for patients with newly diagnosed multiple myeloma.

EP. 4: Role of Monoclonal Antibodies in Up-front Therapy for Multiple Myeloma

April 20th 2021

Rafael Fonseca, MD, discusses the role of monoclonal antibodies in the first-line setting in patients with newly diagnosed multiple myeloma.

EP. 5: Phase 3 MAIA Trial Review

April 20th 2021

Rafael Fonseca, MD, reviews efficacy and safety data from the phase 3 MAIA trial and discusses their implications for clinical practice.